The QualityStocks Daily Thursday, May 31st, 2018

Today's Top 3 Investment Newsletters

MarketClub Analysis (MDGL) +144.96%

StockMarketWatch (VKTX) +101.01%

QualityStocks (NMXS) +35.45%

The QualityStocks Daily Stock List

Timberline Resources Corp. (TLRS)

MarketWatch, InvestorsHub, and Gold Investment Letter reported on Timberline Resources Corp. (TLRS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Timberline Resources Corp. is a gold exploration and development company. Its operational emphasis is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and strong economics. In addition, its exploration efforts have been focused on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. Timberline Resources is based in Coeur d’Alene, Idaho.

Recently, the Company announced that it is refocusing its exploration efforts on advancing the Windfall and Lookout Mountain projects at its Eureka property. This is simultaneous with relinquishing its option to acquire the Talapoosa project.

The Company entered into a transaction with Gunpoint Exploration Ltd. on March 17, 2015. Timberline Resources acquired the option to purchase 100 percent of the Talapoosa project, located in Lyon County, Nevada. The Talapoosa project is where Timberline Resources completed and disclosed a positive Preliminary Economic Assessment (PEA).

Regarding the Eureka land package, it includes the Company’s Lookout Mountain project and a pipeline of earlier-stage projects that feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

Timberline Resources continues to advance its Lookout Mountain and Windfall project areas at Eureka. The Company purchased a large block of patented and unpatented mining claims in 2012. These comprise mainly the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada.

The purchased property package covers 4,100 acres. It consists of 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Last week, Timberline Resources announced that it signed a definitive purchase and sale agreement to acquire ownership interests in two Nevada gold-copper mineral properties situated in the world-class Battle Mountain mining district from Americas Gold Exploration, Inc. (AGEI).

This acquisition includes the right to earn into existing joint venture (JV) agreements with McEwen Mining, Inc. at the Elder Creek Project, and with Lac Minerals (USA) LLC, a wholly-owned subsidiary of Barrick Gold Corporation at the Paiute Project.

Furthermore, last week, Timberline Resources announced that mapping and surface sampling on the Paiute JV project, positioned in the Battle Mountain District of Nevada, have further defined a NNE-trending structural zone, measuring 2,500 meters long by 500 meters wide, which hosts gold-silver mineralization.

The project, situated 2.5 kilometers west of Newmont's Copper Basin copper-gold deposit, also contains a deeper copper-gold porphyry target. Timberline Resources has entered into a definitive agreement with Americas Gold Exploration to acquire a 73.7 percent interest in the Paiute project JV, with the remaining interest owned by a subsidiary of Barrick Gold.

Timberline Resources Corp. (TLRS), closed Thursday's trading session at $0.0711, down 12.70%, on 270,850 volume with 59 trades. The average volume for the last 60 days is 79,785 and the stock's 52-week low/high is $0.065/$0.425.

chart

Amerityre Corp. (AMTY)

Marketbeat, Real Pennies, CoolPennyStocks, TopPennyStockMovers, Money Morning, and Stock Richreported on Amerityre Corp. (AMTY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Amerityre Corp. engages in the research and development (R&D), manufacture, and sale of polyurethane tires. The Company initially developed polyurethane foam tires based on proprietary chemical formulations. It has invented new polyurethane foam and elastomer materials that it believes are superior to rubber in several tire applications.

Amerityre concentrates on three segments of the tire market - closed-cell polyurethane foam tires, polyurethane elastomer forklift tires, and agricultural tires. All of its tires are manufactured in the United States. Amerityre is headquartered in Boulder City, Nevada and the Company lists on the OTC Markets’ OTCQB.

Amerityre has in-house product formulation development and tire design capabilities. The Company can design and manufacture custom tires to address exact client applications.

Amerityre’s advanced polyurethane materials are environmentally friendly. Also, they can be recycled. Regarding agricultural tires, the Company has developed two products for this market, one used in irrigation and one used in planting. Both products have successfully field tested.

The Company has developed a high density, closed cell foam material – using proprietary polyurethane chemical formulations, which it believes are superior in low speed foam tire applications. Amerityre’s materials are UV and ozone resistant and long-lasting. Its foam tires can never go flat; as such, the Company calls them Flatfree™.

Its tires consist of high density foam. They exhibit low rolling resistance. The polyurethane foam tires do not absorb water and suffer performance degradation in wet environments.

The underpinning of Amerityre’s polyurethane material technology is on proprietary formulations. One is closed-cell polyurethane foam. This is a lightweight material with high load-bearing capabilities for low duty cycle applications.

The other is Polyurethane Elastomer Technology - Kryon™ and Elastothane™. Amerityre has created many polyurethane elastomer chemical formulations having superior temperature, abrasion, and elastic properties. These materials are used in forklift tires and agricultural tire applications.

Amerityre reported its first annual profit in Fiscal Year (FY) 2017. Increased Gross Margins from 29.4 percent to 32.6 percent were the driver of the higher profitability. The Company’s Sales Revenue, year-over-year, decreased by 4 percent. Increased sales of larger closed cell foam tires offset unsatisfactory sales in agricultural and industrial tire market segments.

Amerityre’s FY 2018 goal is manufacturing flexibility and capacity optimization. The Company states that the product pricing model is a prominent tool for making business decisions. Its objectives include identifying and developing relationships with new distribution partners to grow overall Sales Revenue by 10 percent. Its objectives also include continuing development of new formulations and new products to address market needs.

 

Amerityre Corp. (AMTY), closed Thursday's trading session at $0.01586, up 3.66%, on 7,000 volume with 1 trade. The average volume for the last 60 days is 32,539 and the stock's 52-week low/high is $0.0124/$0.0349.

chart

Newgioco Group, Inc. (NWGI)

TradingView, OTC Markets, MarketWatch, and LAST10K reported on Newgioco Group, Inc. (NWGI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Newgioco Group, Inc. is a betting software technology business. The Company provides regulated leisure lottery and gaming products and services via licensed subsidiaries based in Europe. Newgioco Group, together with its wholly-owned subsidiaries, is a fully-licensed and integrated gaming software technology company.

Newgioco Group is based in Toronto, Ontario. The Company also has an office in Rome, Italy. The Company was formerly known as Empire Global Corp. It changed its corporate name to Newgioco Group, Inc. in July of 2016.

Newgioco Group conducts its business principally through retail neighborhood betting shops and an internet-based gambling and sports betting software platform under the registered brand Newgioco, through its licensed website www.newgioco.it located in Italy. The Company also offers an inventive betting platform (www.odissea.at) providing B2B (Business-to-Business) and B2C (Business-to-Consumer) bet processing.

Newgioco provides its clients a wide-ranging set of leisure gaming products and services. These include sports betting, virtual sports, online casino, poker, bingo, lottery, and interactive games and slots.

The Company has acquired Multigioco Srl. This is a licensed gaming operator based in Rome. Newgioco Group’s plan is to aggressively go after attractively priced, fragmented, and profitable gaming operators in Italy. Its aim is to become a top-tier gaming operator over a five-year investment time horizon.

Newgioco announced this past January the signing of four new online gaming operators. This further expanded its distribution network in Italy. The four new web skins include www.clubgames.it (Region: Sardegna/Lazio); www.mixbet.it (Region: Campania/Puglia); www.imperialbet.it (Region:Sicilia); and www.quibet.it (Region: Calabria).

Newgioco Group announced this past February the launch of NG PAY payment gateway under a licensing agreement with Euronet Worldwide, Inc. based in Leawood, Kansas. The Company's secure payment gateway through Euronet will be available on the www.ngpay.it website. It will make a wide array of integrated payment, pre-paid remittance and reload solutions available to its registered online customers, partners, webshops, and retail stores.

Recently, Newgioco Group announced the launch of CHATBOT, its first phase of Artificial Intelligence (AI) technology incorporated into its innovative ELYS betting platform by Odissea. CHATBOT is a leading-edge AI betting technology utilizing customized pattern recognition and machine-learning algorithms to ascertain the relevant features of customer interactions and to develop a complete customer betting profile.

In May, Newgioco announced the signing of two new online operators based in Rome and Sardegna. This expands the Company’s distribution network in western Italy.

The new urls www.782-sport.it and www.gamesmart.it went live on May 15, 2018. The expectation is that they will grow Newgioco’s online player base by roughly 500 new registrations monthly and increase annual betting turnover by about $18 million representing an estimated 2.5 percent increase in net gaming revenue.

Newgioco Group, Inc. (NWGI), closed Thursday's trading session at $1.18, down 9.23%, on 33,716 volume with 54 trades. The average volume for the last 60 days is 42,260 and the stock's 52-week low/high is $0.085/$1.78.

chart

Semler Scientific, Inc. (SMLR)

Wall Street Resources, Money Morning, Marketbeat, and Barchart reported earlier on Semler Scientific, Inc. (SMLR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Semler Scientific, Inc. is a medical risk-assessment Company headquartered in San Jose, California. Its mission is to develop, manufacture, and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Semler Scientific provides technology and software solutions to improve the clinical effectiveness of healthcare insurers and physician groups. Semler Scientific lists on the OTC Markets Group’s OTCQB.

In essence, Semler Scientific provides diagnostic and testing services to the U.S.’s leading health plans and providers. The Company’s goal is to develop, manufacture, and market innovative proprietary products and services, which assist its customers in evaluating and treating chronic diseases.

Semler Scientific manufactures the QuantaFlo™ system for Vascular Disease testing. The QuantaFlo™ system is very suitable for use in primary care offices, specialty practices, health fairs, or during home assessments.

The QuantaFlo™ PAD test delivers quick, accurate results in approximately five minutes at the point of care. In March 2015, The Company received Food and Drug Administration (FDA) 510 (k) clearance for the next generation version of QuantaFlo™, which commercially launched in August 2015. The QuantaFlo software can be installed on any Windows based PC, laptop or tablet.

Semler Scientific's first patented and FDA cleared product, introduced commercially in 2011, measured arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease.

In addition, Semler Scientific has its WellChec™ service. WellChec™ provides turn-key assessment testing across the U.S. for an array of conditions. It provides turnkey solutions for administering vital clinical tests that can impact HCC classifications, CPT coding, HEDIS and Quality Measures. In April 2015, Semler launched its multi-test service platform, WellChec™ .

In October 2016, Semler Scientific shifted its marketing focus for WellChec™ from direct contracts with health insurance plans under which it acted as the primary WellChec™ service provider to contracts to supply its software and equipment to vendors who employ medical professionals to do yearly wellness visits for health insurance plans.

Semler Scientific believes that its products position the Company to provide valuable information to its customer base of insurance plans, physicians and risk assessment companies, which subsequently allow them to better guide patient care.

Semler Scientific, Inc. (SMLR), closed Thursday's trading session at $12.25, down 2.00%, on 9,102 volume with 20 trades. The average volume for the last 60 days is 16,887 and the stock's 52-week low/high is $2.77/$13.00.

chart

Cantabio Pharmaceuticals, Inc. (CTBO)

AwesomeStocks, PennyStockScholar, Profitable Trader Authority, HotStockProfits, Profitable Trading, Leeb’s Market Forecast, OTCtipReporter, and Investors Alley reported earlier on Cantabio Pharmaceuticals, Inc. (CTBO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cantabio Pharmaceuticals, Inc. concentrates on bringing novel, first-in-class drug candidates into clinical trials and beyond. The Company does so through the discovery and development of innovative pharmacological chaperone and protein delivery based therapeutics, centering on protein systems implicated in neurodegenerative disorders. These include Alzheimer’s, Parkinson’s, and oxidative stress. Currently, Cantabio Pharmaceuticals is engaging in advanced pre-clinical trials of its therapeutic candidates and is focused on developing these towards clinical trials.

Cantabio Pharmaceuticals, Inc. was created via the merger of Gardedam Therapeutics with Cantabio Pharmaceuticals in November of 2015. A preclinical stage biotechnology enterprise; Cantabio Pharmaceuticals is based in Sunnyvale, California. The Company lists on the OTC Markets Group’s OTCQB.

Cantabio Pharmaceuticals is focusing on commercializing novel therapies and the Intellectual Property (IP) produced from its research and development (R&D) activities for Parkinson’s disease (PD), Alzheimer’s disease (AD), and other related neurodegenerative diseases. Its strategy combines a detailed therapeutic emphasis, target family biophysics, and drug discovery technology and expertise into a unique drug discovery approach.

The Company is also developing therapeutic proteins that can pass through the blood-brain barrier to supplement existing levels of proteins, which display loss of function during disease conditions.

Cantabio Pharmaceuticals has a new preclinical therapeutic program for Alzheimer’s disease that it is pursuing by way of its drug discovery partnership with NovAliX. This program is targeted at the development of small molecule chaperones that stabilize the Abeta peptide, the aggregation of which is considered to be a crucial element in the onset and progression of Alzheimer’s disease.

Cantabio Pharmaceuticals announced that Dr. Gergely Toth, the Company’s Chief Executive Officer, will present results of Cantabio’s DJ-1 protein targeting small molecule pharmacological chaperone therapeutic program at the Neuro4D Conference (Advances in Drug Discovery for Proteopathic Neurodegenerative Diseases) in Mainz, Germany, June 4 - 5, 2018.

The presentations will describe the positive therapeutic activity in cellular and in a MPTP mice model of Parkinson’s disease of Cantabio Pharmaceuticals’ novel DJ-1 protein targeting small molecule drug candidates. The presentations are co-authored by researchers from Purdue University (USA), Novalix SAS (France), Melior Discovery (USA), and the Hungarian Academy of Sciences.

Cantabio Pharmaceuticals, Inc. (CTBO), closed Thursday's trading session at $0.067, down 1.47%, on 2,004 volume with 2 trades. The average volume for the last 60 days is 64,699 and the stock's 52-week low/high is $0.01/$0.19.

chart

Dais Analytic Corp. (DLYT)

HotOTC, SmallCapVoice, CoolPennyStocks, MadPennyStocks, StockEgg, StockRich, Stockpalooza, Money Morning, Penny Stock Rumble, FeedBlitz, M2 Communications, SmallCap Pulse, BullRally, PennyInvest, PennyStockVille, and Greenbackers reported earlier on Dais Analytic Corp. (DLYT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dais Analytic Corp sells its industry-changing nanomaterial technology into the global water, air, and energy markets. A commercial nanotechnology materials enterprise, the Company provides nanotechnology-based applications for heating & cooling, water treatment, and energy storage. It is commercializing its unique Aqualyte™ family of nano-structured materials and processes centering on disruptive air, energy, and water applications. Dais Analytic is headquartered in Odessa, Florida.

The uses of the Aqualyte™ family of nano-structured materials and processes include ConsERV™. This is a commercially available engineered energy recovery ventilator (a heating, ventilation, and air conditioning (HVAC) product).

In addition, the uses include NanoAir™. This is an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle. Uses also include NanoClear™. This is an early beta-stage method for treating contaminated water to provide 1,000 times cleaner potable water.

The NanoClear™ process has consistently shown that Dais Analytic’s novel Aqualyte® material can separate most contaminants from water, realizing almost 'parts per billion' clean product water with little or no fouling of the vital membrane component.

NanoClear™ is a leading-edege water cleaning architecture enabled by the features in the Company’s nanomaterial - Aqualyte™. The NanoClear™ product line is a critical application in purifying contaminated water having high salt content, low pH, or where the requirement for Total Dissolved Solid (TDS) in the product water is 10 or less.

Furthermore uses include NanoCAP™. Dais indicates that NanoCAP™ holds promise to use the Aqualyte™ family to form a disruptive, non-chemical, energy-storage device (an ultra-capacitor) when completed for use in transportation, renewable energy, and also 'smart grid' configurations.

This past summer, Dais Analytic announced it signed a 7 year, non-exclusive agreement with the Menred Group, Zhejiang province, China, to provide its Aqualyte moisture transfer nanomaterial for use in a newer line of Menred energy recovery ventilators (ERV) to sell into the increasing Chinese heating, ventilation and air conditioning (HVAC) market.

Energy Recovery Ventilators are used in association with HVAC equipment to save capital and operating costs. This is while improving the quality of life for the building's occupants.

High effectiveness ERVs, such as ConsERV™ or Menred Group's new line of ERVs to be built utilizing Dais Analytic's Aqualyte nanomaterial, enable architects and engineers to design buildings with considerable volumes of filtered, preconditioned supply air.

Mr. Brian Johnson Dais Analytic’s Chief Technology Officer, said in July 2017, "Dais' ConsERV™ has long been a leader in this field as established by our Air-Conditioning, Heating and Refrigeration Institute (AHRI) certified performance -- along with other similar ratings from 3rd party rating company's worldwide. Our Aqualyte™ nanomaterial, now in its 4th generation, drives this performance and we are excited about working with Menred to bring a new series of ERVs with Aqualyte to the growing Chinese ERV market."

Dais Analytic Corp. (DLYT), closed Thursday's trading session at $0.0595, up 25.26%, on 258,488 volume with 18 trades. The average volume for the last 60 days is 95,759 and the stock's 52-week low/high is $0.01/$0.09.

chart

Net Medical Xpress Solutions, Inc. (NMXS)

Hawk Associates, SmallCapVoice, AMIStockReports, and Lions of Wall Street reported previously on Net Medical Xpress Solutions, Inc. (NMXS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Net Medical Xpress Solutions, Inc. is a leader in the telemedicine field. It specializes in Web-based medical solutions. The Company provides telemedicine programs for diagnostic and clinical medical services. It provides these to mobile companies, urgent cares, and hospitals, trauma centers, imaging centers, jails, nursing homes, corporate health departments and outpatient medical facilities. OTCQB-listed, Net Medical Xpress Solutions has its head office in Albuquerque, New Mexico.

Via its Net Medical Xpress Services, doctors read X-Rays, CT Scans, Ultrasounds, EKGs and more for its clients. Net Medical Xpress provides collaborative tools for quality and secure digital consultations. Being web-based and easy to learn, DICOM files such as X-Rays, Ultrasounds, CTs, MRIs, Echocardiograms, and EKGs are rapidly sent and reports returned.

Net Medical is preparing to deploy new clinical software to provide reassurance to patients recovering from stroke and dealing with other neurological conditions. The goal is for a rural hospital’s providers to be able to assure patients that a return trip to the emergency room may not be needed after being discharged.

Doctors will visit through telemedicine with patients as they recover at home. This is important medically for the patients, and also financially for the insurance companies and the hospitals.

Net Medical Xpress Solutions has its Telemed Building Blocks technology. The technology permits healthcare facilities to set up their own customized telemedicine infrastructure platforms. The Building Blocks technology represents the Company’s most expansive technology launch ever.

Net Medical Xpress Solutions has partnered with eazyScripts. This is to provide electronic prescribing services to patients remotely, through telemedicine physicians who serve populations across the country. eazyScripts is an electronic prescription platform.

The eazyScripts platform provides telemedicine physicians with the ability to submit electronic prescriptions, check prescription fill data, and secure electronic prior authorization at the touch of a button, lessening inefficiencies and errors.

Net Medical Xpress Solutions’ partnership with the University of New Mexico (UNM) is increasing. It is working with the University’s Center for Telehealth to enhance coverage in critical care and Child Ready, a pediatric emergency medical service for rural hospitals in New Mexico, Washington, Wyoming, Minnesota and Oklahoma designed to reduce child mortality. The Company is providing technology for many of UNM’s telemedicine programs.

Net Medical Xpress Solutions designed and built modules include Video Conferencing; Digital Paper Application; Records Server Management; Customer Scheduling; and Forms Editor. Additionally, they include Secure Chat; Diagnostic Report Builder; Provider Cloud Adapter; Net Medical Santa Fe Linux Operating System; and Net Medical Open Source Linux Database.

Net Medical Xpress Solutions, Inc. (NMXS), closed Thursday's trading session at $0.0745, up 35.45%, on 37,412 volume with 5 trades. The average volume for the last 60 days is 30,208 and the stock's 52-week low/high is $0.0351/$0.145.

chart

Titan Medical, Inc. (TITXF)

CoolPennyStocks, OTC Markets Group, StockRich, HotOTC, BullRally, PennyStockVille, MadPennyStocks, and Sharemkt Tips reported previously on Titan Medical, Inc. (TITXF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Titan Medical, Inc. concentrates on the design, development, and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS). Now under development, Titan’s SPORT Surgical System includes a surgeon-controlled robotic platform that features multi-articulating instruments for performing MIS procedures through a single port. A medical device company, Titan Medical is headquartered in Toronto, Ontario.

The SPORT Surgical System is an innovative single incision robotic surgical system. It has undergone development based on clinical user needs. The SPORT Surgical System provides access to underserved market segments, such as ambulatory surgery centers. Concerning Open Display, the 3D high definition 32-inch display provides a premier balance of surgical immersion and situational awareness in the Operating Room (OR).

The design of the SPORT system is to enable surgeons to perform a wide-ranging set of general abdominal, gynecologic, urologic, and colorectal procedures. The design of the system is for improved clinical capabilities, operating room efficiency, as well as hospital economics.

Titan Medical has completed initial formative human factors studies for its SPORT single port robotic surgical system. The Company is planning to commercialize its single incision surgical system - first in Europe and then in the U.S.

In December 2018, Titan Medical reported the successful first use of its SPORT Surgical System in Europe.  These studies in general and urologic surgery at the Institute of Image-Guided Surgery at the Institut Hospitalo-Universitaire de Strasbourg, France are part of the feasibility and validation studies intended to support regulatory submissions.

Recently, Titan Medical announced it was granted U.S. Patent No. 9,925,014, titled “Actuator and Drive for Manipulating a Tool.”  The patent is a continuation patent from earlier issued U.S. Patent No. 9,629,688. It covers Titan Medical’s unique single-port multi-articulated instrument design and, specifically, an orthogonally actuated instrument interface.

Moreover, Titan Medical and Mimic Technologies, Inc. recently announced the collaboration and successful demonstration of a first set of simulation modules for use with Titan Medical’s SPORT Surgical System surgeon workstation.  The successful demonstration of the simulation modules is the initial step in the development of a comprehensive surgeon training curriculum for the SPORT Surgical System. Mimic Technologies is a market leader in robotic simulation.

On April 10, 2018, Titan Medical completed a public offering for gross proceeds of $8,035,941. On April 16, 2018, a surgeon-authored abstract highlighting the early European experience with the SPORT Surgical System was presented at the Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting in Seattle, Washington.

Titan Medical, Inc. (TITXF), closed Thursday's trading session at $0.178, down 3.94%, on 493,111 volume with 86 trades. The average volume for the last 60 days is 571,856 and the stock's 52-week low/high is $0.096/$0.535.

chart

Metrospaces, Inc. (MSPC)

OTC Markets, ClayTrader, Street Insider, Penny Stock Tweets, Stockhouse, Stock of the Week, InvestorsHub, MarketWatch, Emerging Growth, Small Cap Network, Insider Financial, Barchart, WalletInvestor, Investors Hangout, Street Register, and Stockwolf reported on Metrospaces, Inc. (MSPC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Metrospaces, Inc. is a real estate investment and Development Company listed on the OTC Markets. It acquires land, designs builds, and develops then resells condominiums and Luxury High-End Hotels, mainly in urban areas of Latin America. The Company is operated by a premier group of real estate and investment professionals and entrepreneurs located in New York City, Miami, and Buenos Aires.

Metrospaces has its corporate office in New York, New York. The Company has its majority-owned division Etelix.

Metrospaces’ current projects are located in Buenos Aires, Argentina, and Miami. The Company’s majority shareholders have partnered with Investors on elite properties including The London BLVGARI 5 Star Hotel and is presently involved in negotiations for the development of a number of elite luxury properties in South America.

Metrospaces looks to use its international relationships in financing and real estate developers to find co-investment and development opportunities in home building, residential and hotel. The Company will also invest in operating companies that are real estate based. This includes hotel operators and senior facilities operators. Metrospaces will also invest in corporate reorganization.

The Company has strong relationships with Investment Bankers, Real Estate Entrepreneurs, Political Leaders and High Net-Worth Individuals worldwide. Its emphasis is on mid-sized deals.

Metrospaces focuses on joint ventures (JV’s) with established players. Its investment focus includes an equity investments size of $3-4MM per project and geographic diversification.

In April, Metrospaces announced another record revenue month in March 2018 for Etelix.com USA, LLC. Etelix is a Miami-based, FCC-licensed voice, SMS and data/hosting operator. Its principal products and services are global voice wholesale, data and hosting services and it is also a residential and commercial triple-play provider.

In early May, Metrospaces named Italo Segnini as an Independent Board Member to Etelix's Board of Directors.

Metrospaces’ Chief Executive Officer, Mr. Carlos Daniel Silva stated: “Italo is a high-caliber 26-year telco veteran having held senior management positions at Movistar, Televisa Telecom, and Millicom.  Italo’s unique experience in leading revenue growth at such world-class companies will lead our revenue growth to the next stage, as well as allow us to set the stage for growth via acquisitions.”

       

Metrospaces, Inc. (MSPC), closed Thursday's trading session at $0.0005, even for the day, on 25,887,471 volume with 37 trades. The average volume for the last 60 days is 300,800,809 and the stock's 52-week low/high is $0.0000001/$0.0029.

chart

Giga-tronics Incorporated (GIGA)

StockTwits, InvestorsHub, Stockhouse, Stock News Gazette, and SmarterAnalyst reported on Giga-tronics Incorporated (GIGA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Giga-tronics Incorporated produces instruments, subsystems, as well as sophisticated microwave components. These have wide-ranging applications in defense electronics, aeronautics, and wireless telecommunications. Listed on the OTCQB, the Company operates in the Scientific & Technical Instruments industry in the Technology sector. Giga-tronics has its corporate headquarters in Dublin, California.

Giga-tronics works to help solve the world’s next generation Radar and Electronic Warfare problems. It accomplishes this with state-of-the-art high speed signal generators, sub-system and sub-assembly, test and measurement equipment. Giga-tronics product lines include Advanced Signal Generation and Analysis test equipment. It also includes Microsource sub-system and sub-assembly TBRF technology products.

The Company’s Advanced Signal Generator and Analysis System is a family of Real-Time Synthesizers (RTS). The design of these is as modular building blocks for agile signal generation and downconversion of signals with up to 1 GHz of instantaneous bandwidth.

Regarding the Real-Time Threat Emulation System for Electronic Warfare, Giga-tronics’ Threat Emulation Systems (TEmS) permit engineers to imitate real-world environments from bench, chamber, and hangar environments to help identify and fix design issues well before mission day.

Furthermore, the Giga-tronics Multi-Platform Threat Emulation System is a fully integrated combination of multiple COTS configurable systems, sub-systems, software, and numerous kinds of COTS AWGs. These can stream a RF/Microwave scenario, which represents real world threat and target emitters in a complex environment.

Recently, Giga-tronics announced that it received an additional $4.9 million order. This extends continuing production of the Company’s high performance RADAR filters for a major aerospace company. Giga-tronics expects to commence initial shipments of the new order during Q4 of Fiscal 2018. It also expects to complete the bulk of the new order shipments over the succeeding 9 to 12 month period.

Earlier this month, Giga-tronics reported Net Sales for Q2 of Fiscal 2018 of $2.2 million. This represents a 49 percent decrease versus $4.4 million for Q2 of Fiscal 2017. Net Sales for the six-month period ended September 30, 2017 were $4.2 million. This represents a decrease of 46 percent, versus $7.8 million for the six-month period ended September 24, 2016.

This drop in Net Sales for both periods were chiefly because of lower sales associated with the legacy products (sold to Astronics in June of 2016); a drop associated with the Company’s new ASG product; a decrease mainly associated with the winding down of non-recurring engineering services and lower product revenues following the completion of the $4.5 million order for YIG RADAR filters in Q1 of Fiscal 2018.

Giga-tronics Incorporated (GIGA), closed Thursday's trading session at $0.2769, up 19.77%, on 6,498 volume with 10 trades. The average volume for the last 60 days is 15,868 and the stock's 52-week low/high is $0.17/$0.99.

chart

MPX Bioceutical Corporation (MPXEF)

Penny Stock Hub, Stockhouse, MarketWatch, InvestorsHub, Stockwatch, Investorx.ca, 4-Traders, TradingView, OTC Markets, OTC Dynamics, Jet Life Penny Stocks, TalkMarkets, Barchart, Investing News Alerts, and High Rising Stocks reported on MPX Bioceutical Corporation (MPXEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MPX Bioceutical Corporation, by way of its wholly-owned subsidiaries in the U.S., provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona. These businesses operate under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. In addition, MPX Bioceutical has operations in Massachusetts.

MPX Bioceutical is based in Toronto, Ontario. The Company formerly went by the name The Canadian Bioceutical Corporation. It changed its corporate name to MPX Bioceutical Corporation in November of 2017. The Company lists on the OTCQB.

MPX Bioceutical is a multi-state diversified cannabis company. It has operations centered in the U.S. in the adult use and medical cannabis markets. It has completed its agreement to acquire GreenMart operations in Nevada. Also, it signed non-binding Letters of Intent (LOI’s) to purchase dispensary and production licenses in Maryland. Moreover, MPX has applied for a license in Canada.

Concerning Pharma-grade products, the Company signed a definitive agreement to establish a joint venture (JV) with Panaxia. This JV is to develop proprietary, smokeless pharma-grade products using cannabis.

In April, MPX Bioceutical announced the official opening of its newest “Health for Life” medical marijuana dispensary in the Metropolitan Phoenix area. This brings the number of dispensaries under MPX management in Arizona’s Sun Valley to four. The Crimson dispensary will offer the full range of MPX concentrates, a broad assortment of cannabis flower, and a wide selection of 3rd party, processed cannabis-infused edibles.

Additionally, in April, MPX Bioceutical announced that it signed a Letter of Intent (LOI) to acquire 100 percent of the issued and outstanding shares of Canveda, Inc.  Canveda is a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

Canveda is a private company operating in Peterborough, Ontario. It operates from a completely built-out facility, which is ready to start its initial production run and is capable of producing about 1,000-1,200 kilograms of high quality cannabis flower each year. MPX Bioceutical will acquire the Canveda Shares for CDN$18 million.

MPX Bioceutical Corporation (MPXEF), closed Thursday's trading session at $0.629, down 2.75%, on 747,311 volume with 295 trades. The average volume for the last 60 days is 572,987 and the stock's 52-week low/high is $0.2257/$0.935.

chart

Pura Naturals, Inc. (PNAT)

OTC Markets and MarketWatch reported on Pura Naturals, Inc. (PNAT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean by way of its inventive BeBetter Foam®. The Company is the manufacturer of innovative foam cleaning products for the home. It has its proprietary foam technology that absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. OTCQB-listed, Pura Naturals is based in Lake Forest, California.

The Company concentrates on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, such as facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

In addition, the Company has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA).

Pura Naturals’ Marine products are reusable and absorb up to 14 times their weight. Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Company has its Pura Marine division. This division focuses on developing solutions utilizing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors.

Pura Naturals also has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner. The design of it is to cut through very greasy messes to leave behind only a citrus scent. The Pura Pro Bio-Degreaser earlier finished beta-testing with Pura Naturals’ partners in the marine oil transport industry.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). The Company’s household cleaning product delivers a unique soap infusion. The pioneering foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

This past October, Pura Naturals announced strengthening its communications and marketing strategy via the engagement of three strategic partners. JES, the award-winning singer, songwriter, DJ, producer, founder of The Rock Star Diet and soon to be cookbook author, signed a marketing agreement with Pura Naturals. JES will assist Pura Naturals in expanding its product name recognition, enhancing its consumer image, and attracting other celebrity sponsors through its product promotions with JES as a celebrity spokesperson.

Mr. Mark Barile, owner of Barile Environmental, Inc., entered into a consulting services agreement. Mr. Barile will work with Pura Naturals as its expert in supporting and strengthening its environmental product claims.

Furthermore, KCSA Strategic Communications was chosen to lead the strategic communications and investor relations programs of Pura Naturals. KCSA is a New York-based communications firm.

Pura Naturals, Inc. (PNAT), closed Thursday's trading session at $0.018, up 5.88%, on 632,140 volume with 29 trades. The average volume for the last 60 days is 510,239 and the stock's 52-week low/high is $0.0155/$1.15.

chart

The QualityStocks Company Corner

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC PINK: NUGL), the cannabis industry's new standard of technology scales for user-facing feature launch and BETA advertising platform. You can see the latest concepts at http://www.nugl.com/advertise.html.

NUGL Inc. (OTC: NUGL), is a search engine and online directory for the marijuana industry. NUGL’s database includes listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands. The company focuses on leading the evolution in business relations, development and organic data in the cannabis industry with metasearch technology.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.11, off by 1.77%, on 121,799 volume with 128 trades. The average volume for the last 60 days is 105,952 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG).

Medical Cannabis Payment Solutions (OTC: REFG) is a state-of-the-art financial services company serving the medical cannabis and banking industries. The company brought to market the first and only comprehensive card processing operation of its kind.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company’s unique “StateSourced” proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven’t been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin’s cryptocurrency ($Weed) with Medical Cannabis Payment Solutions’ StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

“We’ve completed our transition from development stage to revenue stage,” says Roberts. “We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases.”

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry.

Medical Cannabis Payment Solutions (REFG), closed the day's trading session at $0.0593, up 11.68%, on 398,420 volume with 52 trades. The average volume for the last 60 days is 536,670 and the stock's 52-week low/high is $0.0161/$0.0924.

Recent News

chart

Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

As cryptocurrency markets become more standardized and regulated, both winners and losers will shake out. Realizing these digital mediums of exchange will likely integrate into the global financial system in a significant fashion, evaluating companies that enable cryptocurrency transactions makes sense. Companies at the vanguard of facilitating global cryptocurrency transactions such as Virtual Crypto Technologies Inc. (OTCQB: VRCP).

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website, www.virtual-crypto.com, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.16, off by 0.06%, on 80,111 volume with 20 trades. The average volume for the last 60 days is 38,565 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Every month, SeriousTraders issues a newsletter to its subscribers, jam packed with specialized articles; you won't miss an opportunity to hone your trading edge. Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, a technological innovator in automotive vision systems and driver assistance technology, was highlighted in the newsletter, among many other promising companies.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.9336, up 3.29%, on 115,146 volume with 205 trades. The average volume for the last 60 days is 22,296 and the stock's 52-week low/high is $2.44/$11.70.

Recent News

chart

EVIO, Inc. (EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO Inc., (OTCQB: EVIO) a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that Dr. Anthony Smith, Chief Science Officer of EVIO Inc., will present at the CannaWest Compliance, Testing & Product Safety Summit taking place from June 5-7, at the Crowne Plaza Redondo Beach & Marina Hotel in Los Angeles.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.15, up 3.60%, on 75,378 volume with 67 trades. The average volume for the last 60 days is 73,069 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8)

The QualityStocks Daily Newsletter would like to spotlight Victory Square Technologies Inc. (VSQTF).

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce portfolio company, FansUnite Entertainment Inc. (“FansUnite”), has raised $4,457,750 CAD in a private placement financing (the “Private Placement”) valuing FansUnite at over $17,000,000 CAD.

Victory Square Technologies Inc. (VSQTF) is a venture builder that creates, funds and empowers entrepreneurs working in the fields of blockchain technology, virtual reality, artificial intelligence, personalized health, gaming and film. As a technology incubator, Victory Square invests in game-changing entrepreneurs who are provided access to education programs, global mentorship networks, distribution partners, creative workspaces, resources, and other forms of operational support to help them scale internationally.

Victory Square has made multiple early partnerships and investments in the blockchain space. Approximately three years ago the company incubated and invested in BTL Group, which is now a $150 million dollar TSX-listed company offering blockchain solutions across multiple industries with particular focus on the finance, energy and gaming sectors. BTL’s showcase product – Interbit – is a blockchain platform that facilitates the rapid development of business applications that dramatically improve efficiency. Some of the world’s largest institutions are using Interbit to explore new opportunities on private blockchains.

A new social sports betting platform to be developed by Victory Square’s wholly owned subsidiary, FansUnite Media Inc. As a social sports data platform, FansUnite relies on robust data to allow members of its community to engage with like-minded individuals by collaborating, discussing, and predicting the winners of sporting events with a free virtual currency. The integration of blockchain technology into FansUnite’s social sports data platform could also lead to blockchain initiatives developed by other divisions and subsidiaries of Victory Square.

Integral to the FansUnite platform is the introduction of FAN Tokens, an in-game currency purchased with the cryptocurrency Ethereum that token holders can use to place wagers. FansUnite members will be able to earn FAN Tokens through participation in any number of networking effects identified in the company’s Bounty program.

“Blockchain technology and the inherent security it provides will enable us to push every envelope we can to build the most dynamic and responsive social sports betting platform,” said Darius Eghdami, Co-Founder and Chief Executive Officer of FansUnite. “The opportunity to secure data through Blockchain certainly appeals to the accountant in me and we are confident it will become the gold standard among sports betting sites around the world.”

Company subsidiary Victory Square Health Inc., which serves as the venture arm dedicated to companies focused on the development of solutions in personalized health technologies, has also invested in Personalized Biomarkers Inc. (PBI). PBI develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potential biomarkers have been identified, allowing PBI to enter a $4 billion market opportunity.

“We are excited for the opportunity to partner with Personalized Biomarkers as they have correctly identified a massive market opportunity, and have formed an exceptional team of industry leaders,” said Shafin Diamond Tejani, Chief Executive Officer of Victory Square. “This is another investment that is fully aligned with our newly created subsidiary, and one we expect to significantly impact the landscape of personalized medicine.”

A partnership with Insight Diagnostics Inc., also through Victory Square Health, will focus on the development of a personalized diagnostic solution for the improved management and prevention of Type II diabetes.

The company’s investment in V2 Games, a development and publishing studio of high-quality mobile games, is another example of incubating great ideas. V2 Games is well known for its successful launch of PAC-MAN Bounce and Beast Brawlers, two of the company’s releases that are capturing the gaming world by the millions of downloads.

In a move designed to strengthen its presence in film and entertainment, Victory Square has acquired a 40 percent equity stake in United Film Fund II, LLC, which is producing three major motion pictures in 2017 and 2018 including “What They Had,” starring two-time Academy Award winner Hilary Swank.

“This kind of investment in entertainment and film represents a major plank for our Company going forward and we consider ourselves fortunate to have the opportunity to acquire this 40% stake in the Film Fund,” said Tejani, who has launched more than 40 startups in 21 countries that employ hundreds of people and generate more than $100 million in annual revenues. “We believe it’s another strong initiative in film production for us and our stakeholders,” he added.

Victory Square has strategically positioned itself in the legal cannabis industry through an investment in Tantalus Labs, a Canadian-based cannabis cultivation company. Tantalus Labs optimizes plant health and sustainable cultivation by using a unique, environmentally controlled greenhouse engineered specifically for growing cannabis. Called a “SunLab,” the greenhouse takes 90 percent less electricity, uses filtered rainwater, and cools the growing environment to prevent stagnant moisture, recycling the air every 7 minutes to achieve maximum airflow.

Victory Square and its leadership team have seamlessly transitioned from its former identity as Fantasy 6 Sports Inc, a company focused solely on fantasy sports, mobile gaming and immersive sports, to a strategic technology company that creates, funds and successfully executes leading-edge ideas. A long-time technology entrepreneur and advocate of the industry, Tejani received the Person-of-the-Year Award at the 2017 Technology Impact Awards in British Columbia, a hallmark award category that recognizes betterment of the tech industry through leadership and philanthropic or enterprise skills and talents. Tejani has pledged to match up to $1 million in donated funds to be shared by a number of Canadian endeavors aimed at education and child-safe projects.

“These are exciting and important steps in the evolution and growth of our Company, and which properly and fully align with our strategic plan focusing on our core competencies in Blockchain Technology, Artificial Intelligence, Gaming, Personalized Health, Film and Virtual, Augmented and Mixed Reality,” said Tejani. “We’re spurred on by the success we have had in building on our original forays into fantasy sports, mobile gaming and immersive sports. In addition, we are energized by our most recent initiatives in sports, personalized health and entertainment and the confidence being shown by our shareholders in the dynamic direction of the Company.”

Victory Square Technologies and its management team believe innovation, incubation of excellent ideas and social responsibility are at the core of its growing success.

Victory Square Technologies Inc. (VSQTF), closed the day's trading session at $0.01465, up 3.14%, on 5,921 volume with 13 trades. The average volume for the last 60 days is 38,505 and the stock's 52-week low/high is $0.298/$3.32.

Recent News

chart

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Artificial Intelligence company AnalytixInsight Inc. (TSX-V: ALY; OTCQB: ATIXF) today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 3:30 PM PST. Scott Urquhart, VP Corporate Development of AnalytixInsight will be giving the presentation and meeting with investors. View AnalytixInsight's profile here: https://www.ldmicro.com/profile/ALY.V. Profiles powered by LD Micro - News Compliments of ACCESSWIRE.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed the day's trading session at $0.3456, even for the day. The average volume for the last 60 days is 7,149 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) was highlighted in a report today on how cannabis growers across the market are gearing up for putting their wares in a drinking glass or can.

The Green Organic Dutchman (TSX: TGOD), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $5.67, up 3.47%, 3,660,000 volume. The stock's 52-week low/high is $3.50/$5.48.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA), whose hempSMART™ brand will be among the first CBD products to be marketed on a mass national TV commercial. Growth in hemp-based products is only a piece of the cannabis industry puzzle.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.041, off by 2.15%, on 12,736,758 volume with 648 trades. The average volume for the last 60 days is 4,735,512 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that, subject to ongoing legal and tax analysis, it intends to create two wholly-owned subsidiaries that will respectively hold the intellectual property ("IP") related to, in the case of the first subsidiary, the improved processing and combustion-free delivery of nicotine and nicotine analogs and, in the case of the second subsidiary, delivery of non-steroidal anti-inflammatory drugs ("NSAIDs"), phosphodiesterase ("PDE5") inhibitors and other active pharmaceutical ingredients. Also today, CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article covering Lexaria Bioscience.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.58, up 3.95%, on 127,990 volume with 154 trades. The average volume for the last 60 days is 179,380 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

chart

Hiku Brands Co. Ltd. (DJACF)

The QualityStocks Daily Newsletter would like to spotlight Hiku Brands Co. Ltd. (DJACF).

Hiku Brands Company Ltd. (CSE: HIKU) ("Hiku" or the "Company") is pleased to announce the filing of its financial statements and management discussion and analysis for the first quarter ended March 31, 2018. These filings are available for review on the Company's SEDAR profile at www.sedar.com.

Headquartered in British Columbia’s picturesque Okanagan Valley, Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) iis a premium cannabis lifestyle brand growing high-quality handcrafted cannabis flower. Hiku’s wholly owned subsidiary is a licensed producer of cannabis under the ACMPR that has requested its Pre-Sales License Inspection, the last step prior to receiving a license to sell cannabis under the ACMPR. Hiku’s Dominion Facility is a state-of-the-art ACMPR licensed production facility capable of producing approximately 660 kg year of dried cannabis flower. Hiku’s second facility, a 22,580 sq ft warehouse, “the FUTURE LAB”, is targeting its Phase 1 completion by Q2 2018 and once the facility is fully built-out utilizing an industry leading multi-tier system powered by LED lighting provided by Fluence BioEngineering, Hiku’s annual production capacity is expected to be in excess of 5,000 kgs. Hiku was founded by the proven entrepreneurial team that started SAXX Underwear®.

On December 21, 2017, Hiku and TS Brandco Holdings Inc. (“Tokyo Smoke”) announced that they have entered into a binding Letter of Intent (“LOI”) to merger the two companies and create a uniquely positioned cannabis company combining a best-in-class craft cannabis producer with an award-winning lifestyle brand and retail-focused cannabis company. It is anticipated that the combined company resulting from the merger will use the name “Hiku Brands Company Ltd.” (“Hiku”) to refer to the brand house containing premium cannabis brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku recently closed on a $10 million strategic equity investment from Aphria Inc. (“Aphria”) (TSX:APH and US OTC: APHQF) to expand their product offering ahead of the recreational market.

Upon completion of the merger, Hiku will have a robust cash position of approximately $31 million, which it plans to invest in expanding its cannabis production capacity, growing its retail footprint, and adding select brands to its portfolio through highly strategic and complementary acquisitions.

About Tokyo Smoke
Founded in 2015 by Alan and Lorne Gertner, Tokyo Smoke is an award-winning cannabis lifestyle brand that brings sophistication and design to the fast-growing industry. With immersive experiences and design-first, non-dispensary retail spaces selling coffee, cannabis accessories and design products, the brand has six locations in Canada, with plans to expand nationwide. Recently named “Brand of the Year” at the Canadian Cannabis Awards, Tokyo Smoke has showcased excellence in brand storytelling, and has developed an international reputation as the go-to destination for engaging content offerings within the industry. With the acquisition of fellow designer cannabis brand Van der Pop, and by partnering with Aphria Inc. (TSX: APH and US OTC: APHQF) and WeedMD (TSXV: WMD), Tokyo Smoke continues to be the leading Canadian brand in the cannabis space.

About Hiku
Hiku is focused on handcrafted cannabis production, immersive retail experiences, and building a portfolio of iconic, engaging cannabis lifestyle brands. Hiku is differentiated as the only Canadian craft cannabis producer with a significant national retail footprint and a growing brand house including premium cannabis lifestyle brands DOJA, Tokyo Smoke, and Van der Pop.

Hiku’s wholly owned subsidiary, DOJA Cannabis Ltd., is a federally licensed producer pursuant to the ACMPR, owning two production facilities in the heart of British Columbia’s Okanagan Valley. The company operates a network of retail stores selling coffee, clothing and curated accessories, across British Columbia, Alberta and Ontario.

Hiku Brands Co. Ltd. (DJACF), closed the day's trading session at $1.07, off by 4.46%, on 194,134 volume with 303 trades. The average volume for the last 60 days is 182,178 and the stock's 52-week low/high is $0.20/$3.8799.

Recent News

chart

Pivot Pharmaceuticals Inc. (PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed an Option Agreement with IP Med Inc., based in Oceanside, New York, to acquire an exclusive worldwide license for Trivair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the delivery of Pivot's Ready-To-Infuse-Cannabis ("RTIC") cannabinoid products.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.353, off by 21.15%, on 554,461 volume with 226 trades. The average volume for the last 60 days is 125,665 and the stock's 52-week low/high is $0.047/$2.46.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.